Importantly, JK5G postbiotics may also enhance the composition of the gut microbiota and positively modify the tumour milieu by elevating the levels of circulating CD3+CD4+ T cells and CD4/CD8 ratio.172. The gene discussed is CD8A; the disease is neoplasm.